Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Beta Bionics' 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents detailed voting tallies for two proposals: election of directors (Sean D. Carney and Christy Jones as Class I directors) and ratification of Ernst & Young LLP as the independent auditor. Both proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and audit oversight decisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-22
Item 1.01
Corpay entered into the Eighteenth Amendment to its Credit Facility on May 21, 2026, materially restructuring its debt by increasing revolving commitments by $0.9 billion to $3.7 billion, increasing Term Loan A by $0.4 billion to $3.3 billion, increasing Term Loan B-6 by $2.05 billion to $2.95 billion, and extending maturities by 5 years.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-22
Item 5.07
Shareholders approved a reverse stock split (1-for-5 to 1-for-10 ratio) and amendment to the certificate of incorporation at a special meeting held on May 19, 2026, with 44,826,378 votes in favor, 6,708,960 against, and 102,965 abstained.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-22
Item 8.01
The Board approved and the company announced a 1-for-8 reverse stock split of SCYNEXIS common stock, effective May 29, 2026, which was previously authorized by stockholders and affects share structure, authorized shares, and trading mechanics.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-22
REalloys Inc. entered into a 15-year Rare Earth Product Offtake Agreement with Critical Metals Corp on May 18, 2026, committing to purchase 15% of Phase 1 production from the Tanbreez rare earth element mining project in Greenland. This is a material definitive agreement disclosed under Item 1.01 that establishes a long-term supply commitment with pricing mechanisms tied to market indices and floor prices, representing a significant commercial arrangement that would affect investor assessment of the company's strategic positioning and revenue streams.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The filing discloses interim clinical trial results being presented at a major oncology conference (ASCO 2026). While this could represent material clinical progress for a therapeutics company, the Item 8.01 disclosure lacks sufficient detail to confirm whether these results constitute a formal earnings release, material impairment, or other specific event type. The announcement of interim trial data at a scientific conference is material to investors but does not fit cleanly into the more specific taxonomy categories.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-22
Item 8.01
Dominion Energy disclosed entry into an Agreement and Plan of Merger with NextEra Energy on May 15, 2026, whereby NextEra's subsidiary will merge with Dominion Energy, with Dominion surviving as a wholly owned subsidiary of NextEra. This is a material acquisition/change of control transaction subject to shareholder and regulatory approvals, including HSR clearance and approvals from FERC, NRC, and state utility commissions. The filing extensively discusses closing conditions, risks, and restrictions on Dominion's business pending completion—all hallmarks of a material M&A event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
XOMA Royalty Corp held its 2026 Annual Meeting of Stockholders on May 21, 2026, where stockholders approved five proposals: election of seven directors, ratification of Deloitte & Touche LLP as independent auditor, amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (increasing available shares by 425,000 and extending the term to 2036), approval of the 2026 Employee Stock Purchase Plan (500,000 shares available), and advisory approval of named executive officer compensation. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
Item 5.03
The company adopted bylaw amendments in connection with a pending merger with Ligand Pharmaceuticals, including provisions related to Nevada controlling interest statutes and exclusive forum selection that affect shareholder rights and dispute resolution procedures.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-05-22
Item 8.01
Assembly Biosciences announced a material expansion of its lead clinical candidate ABI-6250 from HDV infection into two additional cholestatic liver disease indications (PBC and PSC), with Phase 2 trials planned for Q4 2026 and Q1 2027, supported by preclinical data and constructive FDA pre-IND meeting feedback.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder voting results from the May 20, 2026 Annual Meeting of Stockholders, including election of two Class III directors (Alan B. Miller and Nina Chen-Langenmayr), advisory approval of named executive compensation, ratification of PricewaterhouseCoopers as independent auditor, and rejection of a stockholder proposal on shareholder money at risk reporting. The filing provides detailed vote tallies for each proposal, which is the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-05-22
Item 5.02
The disclosure centers on a compensatory arrangement modification for Francis X. Brown III, the Interim Principal Financial and Accounting Officer. The Company amended his consulting agreement on May 18, 2026 to change compensation from a fixed hourly rate to $26,000 per month, which is a material modification to executive compensation terms. While Brown's appointment as Interim PAO was previously announced, this Item 5.02(e) filing focuses on the amended compensation structure, making exec_compensation the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-22
Item 5.07
William K. 'Dan' Daniel was elected as Independent Chairman of the Board of Directors at the Annual Meeting, a material appointment to a senior governance role.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The filing discloses a revised, unsolicited acquisition proposal from Bradley L. Radoff, Michael Torok, and affiliates received on May 14, 2026. While this involves potential M&A activity, the proposal is explicitly characterized as "highly contingent, non-binding and unsolicited," which distinguishes it from a definitive agreement or binding transaction. The disclosure is material to investors as it signals potential change-of-control activity, but the contingent and non-binding nature prevents classification as a completed or definitive ma_activity event.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-05-22
Item 8.01
This disclosure describes a putative stockholder class action filed against MasterCraft challenging a stockholders agreement provision and a certificate of amendment filing. Although the claims were mooted through settlement and amendment, the Company agreed to pay $425,000 in attorneys' fees and expenses, and the Court entered an order closing the action on May 19, 2026. This settlement of material litigation is a significant event affecting the registrant's financial position and would be material to a reasonable investor.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The Index Provider announced on May 19, 2026, a change to the Constituent Trading Platforms used to calculate the Index Price for the Fund's components (Bitcoin, Ether, SOL, and BNB). The addition of OSL, Bybit, and Gemini as trading venues affects how the Fund values its holdings and calculates net asset value. While this is an operational/methodological change rather than a discrete event like M&A, restatement, or litigation, it is material to investors because it directly impacts the pricing mechanism and valuation of the Fund's assets.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-22
Item 8.01
The disclosure presents pro forma financial statements reflecting a "Merger" as if completed on specified dates (March 31, 2026 for balance sheet; January 1, 2025 for operations). This is a standard Item 8.01 disclosure accompanying a material acquisition or merger transaction. The pro forma presentation is a hallmark of M&A activity disclosure under Items 1.01 or 2.01, and the language "as if the Merger had been completed" confirms a significant business combination event material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 filing discloses the results of MGE Energy's Annual Meeting of Shareholders held on May 19, 2026, including voting outcomes for three Class I Director elections (James G. Berbee, Londa J. Dewey, and Angela S. Rieger), ratification of PricewaterhouseCoopers LLP as independent auditor, and an advisory vote on executive compensation. The detailed vote tallies (For, Against, Abstained, and Broker Non-Votes) for each matter are the core disclosure, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Bain Capital Private Credit's 2026 Annual Meeting of Shareholders held on May 21, 2026. The filing reports the results of two proposals: (1) re-election of three Class I Trustees (Amy Butte, Thomas A. Hough, and Clare S. Richer), each receiving 26,564,523.54 votes for and zero against; and (2) ratification of PricewaterhouseCoopers LLP as the independent auditor, also approved with 26,564,523.54 votes for and zero against. This is a routine but material disclosure of shareholder meeting outcomes required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports final voting tallies for Proposal 1 (re-election of three Class I Directors: Amy Butte, Thomas A. Hough, and Clare S. Richer) and Proposal 2 (ratification of PricewaterhouseCoopers LLP as independent auditor), with detailed vote counts for and against each proposal. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcome of corporate governance elections.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-22
Item 2.02
The filing discloses a quarterly report released on May 22, 2026, containing unaudited financial information for the period ended March 31, 2026, along with a letter from the President and CEO. This is a standard earnings release disclosure under Item 2.02, providing shareholders with quarterly financial results and management commentary.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-22
Item 1.01
NARC II and NMAC entered into an Underwriting Agreement for the issuance and sale of approximately $1.27 billion in notes by Nissan Auto Receivables 2026-A Owner Trust, a material securitization transaction involving the transfer of retail installment sales contracts and issuance of asset-backed securities.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The filing discloses a prospectus for approximately $1.27 billion in aggregate principal amount of asset-backed notes issued by Nissan Auto Receivables 2026-A Owner Trust, structured across seven classes. While this represents a material securitization transaction, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is a structured finance offering of asset-backed securities backed by an auto receivables pool. This is material to investors but best classified as other_material given the specialized securitization structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a Form 8-K Item 5.07 disclosure of shareholder voting results from CVB Financial Corp.'s 2026 Annual Meeting held on May 20, 2026. The filing reports the results of three proposals: election of ten directors, a non-binding say-on-pay vote, and ratification of KPMG LLP as the independent auditor. All proposals were approved by the requisite voting power, with detailed vote tallies provided for each nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-22
Item 5.07
Item 5.07 explicitly discloses the results of NOV Inc.'s Annual Meeting of Stockholders held on May 20, 2026, with detailed voting tallies for three matters: election of nine directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a textbook shareholder_vote_results disclosure with complete voting data for each proposal.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-22
Item 8.01
Chase Issuance Trust entered into underwriting and terms agreements on May 21, 2026 for the issuance of $1.25 billion in Class A(2026-1) CHASEseries Notes, with closing expected May 28, 2026. While this is a debt issuance rather than equity, the structured finance nature (asset-backed securities backed by credit card receivables) and the material size ($1.25B) make this a significant capital-raising event. The filing discloses the underwriting agreement, tax opinion, and depositor certification typical of ABS offerings. This is classified as dilutive_issuance as the closest match, though it is technically a debt offering rather than equity; alternatively, this could be other_material as a significant structured finance transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-05-22
Item 1.01
Byline Bancorp entered into the Third Amendment to its credit agreement with CIBC Bank USA on May 22, 2026, renewing a $15 million revolving line of credit and extending the maturity date to May 23, 2027. This is a routine renewal and extension of an existing credit facility that confirms continued access to liquidity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Tempus AI's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents final voting tallies for three proposals: (1) election of nine directors with detailed vote counts for each nominee, (2) ratification of PricewaterhouseCoopers LLP as independent auditor, and (3) advisory vote on compensation vote frequency (three-year result). These are routine but material shareholder meeting outcomes that affect board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on three matters: election of 10 board nominees (all elected), non-binding advisory vote on named executive officer compensation (approved), and ratification of Deloitte and Touche LLP as independent auditor (ratified). This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-22
Item 8.01
The filing discloses the Board's intention to appoint Bob Holmen as chair of the Nominating and Corporate Governance Committee effective June 12, 2026, contingent on stockholder approval of Required Company Stockholder Matters at the June 10, 2026 Annual Meeting. While the filing also mentions Karen Vousden's delayed appointment request, the principal disclosed action is the appointment of Holmen to a committee chair role, making exec_appointment the most salient classification. Board reconstitution and committee leadership changes are material to investors assessing governance structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
Wendy's held its 2026 Annual Meeting of Stockholders on May 20, 2026, with shareholders voting on five proposals: election of 8 directors (all approved), amendment to the 2020 Omnibus Award Plan increasing available shares by 21 million (approved), ratification of auditors (approved), advisory say-on-pay vote (approved), and a stockholder proposal on blank-check preferred stock (approved).
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
Item 8.01
This Item 8.01 disclosure announces May 2026 distributions ($0.165 gross per share across three share classes), reports NAV per share of $26.36 as of April 30, 2026, and provides an update on the Fund's continuous offering status and capital raised ($553.2 million total consideration across registered and private placements). While distribution declarations and NAV reporting are routine for closed-end funds, the combination of distribution amounts, NAV, leverage metrics (0.89x debt-to-equity), and offering progress would be material to investors assessing the Fund's income generation and capital structure. However, this does not fit neatly into the more specific event categories (not an earnings release, M&A, impairment, or executive change), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
TScan held its Annual Meeting on May 20, 2026, with shareholders voting on four proposals: election of Class II directors (Katina Dorton and R. Keith Woods), ratification of Deloitte & Touche LLP as independent auditor, approval of an amendment to increase authorized common shares from 300 million to 600 million, and approval to adjourn the meeting. The increase in authorized shares is material to investors as it expands the company's capacity for equity issuance and signals potential future capital-raising or dilution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
SS&C Technologies held an Annual Meeting of stockholders at which shareholders voted on director elections (Normand A. Boulanger, David A. Varsano, Michael J. Zamkow as Class I directors), a non-binding advisory vote on named executive officer compensation, appointment of PricewaterhouseCoopers LLP as independent auditor, and approval of the Third Amended and Restated 2023 Stock Incentive Plan. The Item 5.07 disclosure presents the tabulated results of these governance and compensation-related matters.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 8.01
The Board of Directors authorized a renewal and increase of the company's stock repurchase program to $1.5 billion, representing a material capital allocation decision that affects shareholder value and the company's financial strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-22
Item 7.01
The disclosure announces the launch of exchange offers and consent solicitations for outstanding senior notes, with the Company offering newly issued 9.000% First Lien Notes and 9.750% Second Lien Notes in exchange. This constitutes a material capital restructuring transaction involving the refinancing and exchange of existing debt obligations, which would materially affect the registrant's financial condition and capital structure. The cautionary language acknowledging that failure to complete the transaction "could materially adversely affect" the Company's financial condition further underscores materiality.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure presents the final voting results from MasTec's Annual Meeting held on May 21, 2026, covering three proposals: election of three Class I directors (Csiszar, Johnson, and Mas), ratification of PwC as independent auditor, and advisory vote on named executive officer compensation. The tabulated vote counts for each proposal are the core content of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the certified results of JFrog's annual general meeting held on May 20, 2026. The filing presents voting outcomes for six proposals: re-election of four Class III directors, approval of non-employee director compensation, ratification of auditor re-appointment, advisory vote on named executive officer compensation, and approval of compensation changes for the CEO and CTO. All proposals passed with majority affirmative votes, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 filing discloses the final results of Waters Corporation's annual meeting of stockholders held on May 21, 2026, including voting outcomes on three proposals: election of 11 directors (all re-elected), ratification of PricewaterhouseCoopers LLP as independent auditor (approved), and a non-binding advisory vote on named executive officer compensation (adopted). The detailed vote tallies and passage of all matters are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-22
Item 8.01
American Healthcare REIT closed a public offering of 14,000,000 shares of common stock on May 22, 2026, with an additional 2,100,000 shares available under an underwriter option. The filing discloses a forward sale agreement structure where shares were borrowed and sold to hedge the forward purchaser's obligations, with settlement expected by May 20, 2028. This is a material equity issuance that will dilute existing shareholders and raise capital for general corporate purposes and potential investments.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-22
Item 1.01
Americold entered into a Fourth Amendment to its Credit Agreement on May 18, 2026, extending the maturity date of a $250 million Delayed Draw Term Facility from June 19, 2026 to September 19, 2026. This debt facility extension is material to investors assessing the company's liquidity and refinancing risk.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-22
Item 8.01
The filing discloses the expiration of the Hart-Scott-Rodino Act waiting period for Eli Lilly's acquisition of Centessa Pharmaceuticals plc, a material milestone in the transaction announced on March 31, 2026. The disclosure explicitly states this satisfies "one of the conditions to the closing of the Acquisition" and references the Transaction Agreement, Scheme of Arrangement, and pending shareholder approval and High Court sanction—all hallmarks of a material M&A transaction that would significantly affect the registrant's future.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This Item 5.07 disclosure reports the results of SBA Communications' 2026 Annual Meeting of Shareholders held on May 22, 2026, including voting outcomes on three proposals: election of three Class III directors (Proposal 1), advisory approval of named executive officer compensation (Proposal 2), and ratification of Ernst & Young LLP as independent auditor (Proposal 3). The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Vote) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 20, 2026, filed under Item 5.07. The filing reports voting outcomes on five matters: election of seven directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, approval of the Third Amendment to the 2013 Omnibus Incentive Plan, and ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities, and the disclosure includes detailed vote tallies (For, Against, Abstentions, Broker Non-Votes) for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-22
Item 5.07
This 8-K Item 5.07 discloses the final results of voting at the Company's annual meeting of stockholders held on May 21, 2026. The filing reports the election of three Class III directors (Hurley Doddy, Michael Fishman, and Robert Stanley) and ratification of KPMG LLP as the independent registered public accounting firm. These are routine but material shareholder votes that affect board composition and auditor retention.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-22
Item 5.02
Michael Fishman was appointed as a trustee and Chairman of the Board of Sixth Street Lending Partners effective May 21, 2026. The disclosure centers on his appointment to these leadership roles, with detailed background on his 30+ years of executive experience in corporate lending and credit markets. While Fishman is already a Vice President of the Company, his elevation to Board Chair represents a material change in governance and executive leadership that would affect investor assessment of the company's direction and oversight.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-22
Item 5.02
Shareholders approved an amendment and restatement of the Flexible Stock Plan, increasing available shares by 4.0 million, extending the plan term, adding a non-employee director compensation limit of $750,000, and imposing CEO share-holding requirements.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-22
Item 1.02
The Company terminated a material definitive agreement with CEO Karl G. Glassman regarding aircraft time-sharing for personal use and announced the planned sale of company aircraft, representing a material change in executive perquisites and company asset strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 40%
filed 2026-05-22
Item 1.01
Generation Income Properties entered into a $3.8 million Commercial Business Loan Agreement with Hancock Whitney Bank to refinance existing mortgage indebtedness on two properties, creating a direct financial obligation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from Targa Resources' 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents detailed vote tallies for three proposals: election of four Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditors, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →